David M Murray1, Jennifer Villani2, Ashley J Vargas2, Jocelyn A Lee2, Ranell L Myles2, Jessica Y Wu3, Patricia L Mabry4, Sheri D Schully2. 1. Office of Disease Prevention, NIH, Rockville, Maryland. Electronic address: david.murray2@nih.gov. 2. Office of Disease Prevention, NIH, Rockville, Maryland. 3. University of California Research Initiatives, University of California, Office of the President, Oakland, California. 4. Indiana University Network Science Institute and School of Public Health-Bloomington, Indiana University, Bloomington, Indiana.
Abstract
INTRODUCTION: This paper provides the first detailed analysis of the NIH prevention research portfolio for primary and secondary prevention research in humans and related methods research. METHODS: The Office of Disease Prevention developed a taxonomy of 128 topics and applied it to 11,082 projects representing 91.7% of all new projects and 84.1% of all dollars used for new projects awarded using grant and cooperative agreement activity codes that supported research in fiscal years 2012-2017. Projects were coded in 2016-2018 and analyzed in 2018. RESULTS: Only 16.7% of projects and 22.6% of dollars were used for primary and secondary prevention research in humans or related methods research. Most of the leading risk factors for death and disability in the U.S. were selected as an outcome in <5% of the projects. Many more projects included an observational study, or an analysis of existing data, than a randomized intervention. These patterns were consistent over time. CONCLUSIONS: The appropriate level of support for primary and secondary prevention research in humans from NIH will differ by field and stage of research. The estimates reported here may be overestimates, as credit was given for a project even if only a portion of that project addressed prevention research. Given that 74% of the variability in county-level life expectancy across the U.S. is explained by established risk factors, it seems appropriate to devote additional resources to developing and testing interventions to address those risk factors. Published by Elsevier Inc.
INTRODUCTION: This paper provides the first detailed analysis of the NIH prevention research portfolio for primary and secondary prevention research in humans and related methods research. METHODS: The Office of Disease Prevention developed a taxonomy of 128 topics and applied it to 11,082 projects representing 91.7% of all new projects and 84.1% of all dollars used for new projects awarded using grant and cooperative agreement activity codes that supported research in fiscal years 2012-2017. Projects were coded in 2016-2018 and analyzed in 2018. RESULTS: Only 16.7% of projects and 22.6% of dollars were used for primary and secondary prevention research in humans or related methods research. Most of the leading risk factors for death and disability in the U.S. were selected as an outcome in <5% of the projects. Many more projects included an observational study, or an analysis of existing data, than a randomized intervention. These patterns were consistent over time. CONCLUSIONS: The appropriate level of support for primary and secondary prevention research in humans from NIH will differ by field and stage of research. The estimates reported here may be overestimates, as credit was given for a project even if only a portion of that project addressed prevention research. Given that 74% of the variability in county-level life expectancy across the U.S. is explained by established risk factors, it seems appropriate to devote additional resources to developing and testing interventions to address those risk factors. Published by Elsevier Inc.
Authors: David M Murray; Wilma Peterman Cross; Denise Simons-Morton; Jody Engel; Barry Portnoy; Jessica Wu; Paris A Watson; Susanne Olkkola Journal: Am J Public Health Date: 2015-01 Impact factor: 9.308
Authors: Ali H Mokdad; Katherine Ballestros; Michelle Echko; Scott Glenn; Helen E Olsen; Erin Mullany; Alex Lee; Abdur Rahman Khan; Alireza Ahmadi; Alize J Ferrari; Amir Kasaeian; Andrea Werdecker; Austin Carter; Ben Zipkin; Benn Sartorius; Berrin Serdar; Bryan L Sykes; Chris Troeger; Christina Fitzmaurice; Colin D Rehm; Damian Santomauro; Daniel Kim; Danny Colombara; David C Schwebel; Derrick Tsoi; Dhaval Kolte; Elaine Nsoesie; Emma Nichols; Eyal Oren; Fiona J Charlson; George C Patton; Gregory A Roth; H Dean Hosgood; Harvey A Whiteford; Hmwe Kyu; Holly E Erskine; Hsiang Huang; Ira Martopullo; Jasvinder A Singh; Jean B Nachega; Juan R Sanabria; Kaja Abbas; Kanyin Ong; Karen Tabb; Kristopher J Krohn; Leslie Cornaby; Louisa Degenhardt; Mark Moses; Maryam Farvid; Max Griswold; Michael Criqui; Michelle Bell; Minh Nguyen; Mitch Wallin; Mojde Mirarefin; Mostafa Qorbani; Mustafa Younis; Nancy Fullman; Patrick Liu; Paul Briant; Philimon Gona; Rasmus Havmoller; Ricky Leung; Ruth Kimokoti; Shahrzad Bazargan-Hejazi; Simon I Hay; Simon Yadgir; Stan Biryukov; Stein Emil Vollset; Tahiya Alam; Tahvi Frank; Talha Farid; Ted Miller; Theo Vos; Till Bärnighausen; Tsegaye Telwelde Gebrehiwot; Yuichiro Yano; Ziyad Al-Aly; Alem Mehari; Alexis Handal; Amit Kandel; Ben Anderson; Brian Biroscak; Dariush Mozaffarian; E Ray Dorsey; Eric L Ding; Eun-Kee Park; Gregory Wagner; Guoqing Hu; Honglei Chen; Jacob E Sunshine; Jagdish Khubchandani; Janet Leasher; Janni Leung; Joshua Salomon; Jurgen Unutzer; Leah Cahill; Leslie Cooper; Masako Horino; Michael Brauer; Nicholas Breitborde; Peter Hotez; Roman Topor-Madry; Samir Soneji; Saverio Stranges; Spencer James; Stephen Amrock; Sudha Jayaraman; Tejas Patel; Tomi Akinyemiju; Vegard Skirbekk; Yohannes Kinfu; Zulfiqar Bhutta; Jost B Jonas; Christopher J L Murray Journal: JAMA Date: 2018-04-10 Impact factor: 56.272
Authors: Laura Dwyer-Lindgren; Amelia Bertozzi-Villa; Rebecca W Stubbs; Chloe Morozoff; Johan P Mackenbach; Frank J van Lenthe; Ali H Mokdad; Christopher J L Murray Journal: JAMA Intern Med Date: 2017-07-01 Impact factor: 21.873
Authors: Jennifer Villani; Sheri D Schully; Payam Meyer; Ranell L Myles; Jocelyn A Lee; David M Murray; Ashley J Vargas Journal: Am J Prev Med Date: 2018-10-25 Impact factor: 5.043
Authors: Sheila E Fleischhacker; Catherine E Woteki; Paul M Coates; Van S Hubbard; Grace E Flaherty; Daniel R Glickman; Thomas R Harkin; David Kessler; William W Li; Joseph Loscalzo; Anand Parekh; Sylvia Rowe; Patrick J Stover; Angie Tagtow; Anthony Joon Yun; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2020-09-01 Impact factor: 7.045
Authors: Anna Gaysynsky; Camella J Rising; Neha Trivedi; Kelly D Blake; Wen-Ying Sylvia Chou; April Oh; Robin C Vanderpool Journal: Cancer Causes Control Date: 2021-07-27 Impact factor: 2.506
Authors: Ashley J Vargas; Kyle Sprow; Jennifer L Lerman; Jennifer Villani; Karen S Regan; Rachel M Ballard Journal: Am J Prev Med Date: 2019-12 Impact factor: 5.043
Authors: Abigail A Fagan; Brian K Bumbarger; Richard P Barth; Catherine P Bradshaw; Brittany Rhoades Cooper; Lauren H Supplee; Deborah Klein Walker Journal: Prev Sci Date: 2019-11